Linking pages
- Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports - The New York Times https://www.nytimes.com/2024/04/17/health/sleep-apnea-obesity-zepbound.html 2 comments
- Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study - The New York Times https://www.nytimes.com/2024/02/05/health/zepbound-mounjaro-blood-pressure-tirzepatide.html 1 comment
- Inside Novo Nordisk, the Company Behind Ozempic and Wegovy - The New York Times https://www.nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html 1 comment
Linked pages
- Tirzepatide Once Weekly for the Treatment of Obesity | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2206038 113 comments
- Where Ozempic, Wegovy and New Weight Loss Drugs Came From - The New York Times https://www.nytimes.com/2023/08/17/health/weight-loss-drugs-obesity-ozempic-wegovy.html 7 comments
- Does Ozempic Stop Working Over Time? Why Weight Loss Can Plateau - The New York Times https://www.nytimes.com/2023/09/18/well/ozempic-weight-loss-plateau.html 5 comments
- What Is Ozempic and Why Is It Getting So Much Attention? - The New York Times https://www.nytimes.com/2022/11/22/well/ozempic-diabetes-weight-loss.html 2 comments
- Risks of Ozempic, Wegovy and Other Weight Loss Drugs for People Over 65 - The New York Times https://www.nytimes.com/2023/07/17/well/ozempic-wegovy-risks-older.html 1 comment
Related searches:
Search whole site: site:nytimes.com
Search title: F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy - The New York Times
See how to search.